Evangelisches Klinikum Bethel gGmbH

At Evangelisches Klinikum Bethel gGmbH in Bielefeld, pediatric research in hematologic and lymphatic diseases focuses on improving outcomes for children and adolescents with cancers such as myeloid leukemia in children with Down syndrome, mature aggressive B-cell lymphoma and leukemia, and standard-risk ALK-positive anaplastic large cell lymphoma. These studies are designed to refine treatment approaches, strengthen survival results, and better understand long-term disease control.

• Myeloid leukemia in children with Down syndrome – evaluating treatment effectiveness and survival
• Mature aggressive B-cell lymphoma and leukemia – testing ways to improve event-free survival and immune recovery
• ALK-positive anaplastic large cell lymphoma – assessing whether simpler therapy can still maintain strong cure rates

This area combines pediatric oncology and blood cancer research with a clear goal of making therapies safer and more effective for young patients.

The site is also active in solid tumor and broader neoplasm research, with trials addressing Ewing sarcoma, malignant extracranial germ cell tumours, medulloblastoma, high-risk neuroblastoma, and stage IV childhood renal tumour. The main focus is on testing better treatment strategies, improving response rates, and preserving long-term outcomes in children and adolescents with cancer.

• Ewing sarcoma – studying treatment optimization to improve event-free survival
• Malignant extracranial germ cell tumours – comparing therapies to maintain cure rates while reducing treatment burden
• Medulloblastoma – evaluating risk-adapted approaches for different biological subgroups
• High-risk neuroblastoma – investigating intensified and immune-based strategies for better disease control
• Childhood renal tumour with metastasis – assessing preoperative treatment effectiveness in advanced disease

Together, these trials reflect a strong emphasis on pediatric cancer care, with research aimed at making treatment more precise and more effective for difficult-to-treat tumors.

Research in nutritional and metabolic diseases includes studies in type 1 diabetes mellitus, with attention to long-term safety and disease management in young people. At Evangelisches Klinikum Bethel gGmbH, this work supports better understanding of immune-related treatment effects and the ongoing care needs of children and adolescents living with chronic metabolic disease.

• Type 1 diabetes mellitus – evaluating long-term safety of a therapy aimed at preserving disease control

The research contributes to endocrinology and pediatric chronic disease management, with a focus on safer, more durable treatment strategies.

In respiratory tract disease research, the site studies conditions such as respiratory distress syndrome in preterm infants and severe asthma exacerbations in preschool children. These trials aim to improve breathing outcomes early in life and reduce serious flare-ups in young children with asthma.

• Respiratory distress syndrome in preterm infants – testing ways to improve longer-term lung function
• Severe asthma exacerbations in preschool asthma – evaluating add-on treatment to prevent serious attacks

This area highlights neonatal care and pediatric pulmonology, with research centered on better symptom prevention and healthier lung development.